Overview
- 35 inspections across 34 sites are on record.
- 42 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-11-16.
At a glance
Inspections
35
Sites
34
Observations
42
Career since
Jan 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aaron L. Ellenbogen, D.O. | 16 Nov 2023 | Human Drugs | |
| L. Perrigo Company | 6 Oct 2023 | Human Drugs | |
| Eli Lilly & Company | 15 Sep 2023 | Human Drugs | View 483 → |
| Miguelangelo J. Perez-Cruet, M.D., M.S. | 25 Aug 2023 | Medical Devices & Rad Health | View 483 → |
| Nayana S. Dekhne, M.D. | 20 Jul 2023 | Medical Devices & Rad Health |
Sites inspected
Aaron L. Ellenbogen, D.O.Farmington Hills, United States1 insp.
L. Perrigo CompanyAllegan, United States1 insp.
Eli Lilly & CompanyIndianapolis, United States1 insp.
Miguelangelo J. Perez-Cruet, M.D., M.S.Waterford Township, United States1 insp.
Nayana S. Dekhne, M.D.Royal Oak, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew J Gretkierewicz7 shared
Dina A Tallman4 shared
Corrine M Carter4 shared
Melisa A Healy3 shared
Sherri J Jackson2 shared
Chelsea W Lamm1 shared
Daniel B Bordt1 shared
Lesley Mae P Lutao1 shared
Andrace Deyampert1 shared
Denise L Burosh1 shared
Full investigator report
Get the verbatim findings behind Jennifer A Kemp's 42 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site